Casdin Capital as of Dec. 31, 2023
Portfolio Holdings for Casdin Capital
Casdin Capital holds 36 positions in its portfolio as reported in the December 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Revolution Medicines (RVMD) | 16.1 | $164M | 5.7M | 28.68 | |
| Biolife Solutions Com New (BLFS) | 13.9 | $142M | 8.7M | 16.25 | |
| Sarepta Therapeutics (SRPT) | 9.5 | $97M | 1.0M | 96.43 | |
| Relay Therapeutics (RLAY) | 8.0 | $81M | 7.4M | 11.01 | |
| Illumina Call Option (ILMN) | 4.6 | $47M | 338k | 139.24 | |
| Structure Therapeutics Sponsored Ads Call Option (GPCR) | 4.5 | $46M | 1.1M | 40.76 | |
| Intellia Therapeutics (NTLA) | 4.3 | $44M | 1.5M | 30.49 | |
| Verve Therapeutics (VERV) | 4.1 | $42M | 3.0M | 13.94 | |
| Alnylam Pharmaceuticals (ALNY) | 3.7 | $37M | 195k | 191.41 | |
| Somalogic Class A Com | 3.1 | $32M | 13M | 2.53 | |
| EXACT Sciences Corporation (EXAS) | 3.1 | $31M | 420k | 73.98 | |
| Blueprint Medicines (BPMC) | 3.0 | $30M | 326k | 92.24 | |
| Pliant Therapeutics (PLRX) | 2.8 | $29M | 1.6M | 18.11 | |
| Denali Therapeutics (DNLI) | 2.7 | $28M | 1.3M | 21.46 | |
| 4d Molecular Therapeutics In (FDMT) | 2.1 | $21M | 1.0M | 20.26 | |
| Tenaya Therapeutics (TNYA) | 2.0 | $21M | 6.4M | 3.24 | |
| Beam Therapeutics (BEAM) | 1.4 | $14M | 528k | 27.22 | |
| Abcellera Biologics (ABCL) | 1.3 | $14M | 2.4M | 5.71 | |
| Tango Therapeutics (TNGX) | 1.2 | $12M | 1.2M | 9.90 | |
| Century Therapeutics (IPSC) | 1.0 | $11M | 3.2M | 3.32 | |
| Avidity Biosciences Ord (RNA) | 1.0 | $11M | 1.2M | 9.05 | |
| Neurogene (NGNE) | 1.0 | $10M | 525k | 19.38 | |
| Pacific Biosciences of California (PACB) | 1.0 | $10M | 1.0M | 9.81 | |
| Genedx Holdings Corp Com Cl A (WGS) | 0.8 | $8.5M | 3.1M | 2.75 | |
| Fate Therapeutics (FATE) | 0.8 | $7.7M | 2.1M | 3.74 | |
| Codexis (CDXS) | 0.6 | $6.1M | 2.0M | 3.05 | |
| 2seventy Bio Common Stock (TSVT) | 0.5 | $5.0M | 1.2M | 4.27 | |
| Absci Corp (ABSI) | 0.4 | $4.1M | 973k | 4.20 | |
| Prime Medicine (PRME) | 0.3 | $3.3M | 367k | 8.86 | |
| Syndax Pharmaceuticals (SNDX) | 0.3 | $3.2M | 150k | 21.61 | |
| Monte Rosa Therapeutics (GLUE) | 0.3 | $2.9M | 511k | 5.65 | |
| D Fluidigm Corp Del (LAB) | 0.3 | $2.7M | 1.2M | 2.21 | |
| Exscientia Ads (EXAI) | 0.1 | $1.4M | 214k | 6.41 | |
| Lianbio Sponsored Ads (LIANY) | 0.1 | $923k | 206k | 4.47 | |
| Singular Genomics Systems In | 0.1 | $609k | 1.3M | 0.46 | |
| Kronos Bio (KRON) | 0.0 | $155k | 124k | 1.25 |
